- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04709588
Hydrolyzed Collagen Combined With Djulis and Green Caviar Improve Skin Condition
January 12, 2021 updated by: TCI Co., Ltd.
Collagen combined with djulis and green caviar improve skin condition
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Using collagen drinks combined fish collagen with djulis, and green caviar to improve skin condition.
Study Type
Interventional
Enrollment (Actual)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan
- Research & Design Center, TCI CO., Ltd
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Dry skin
- Rough skin
- Large pores
- Dark yellow complexion
- Sagging skin
Exclusion Criteria:
- Skin disorders
- Liver diseases
- Kidney diseases
- Allergy to cosmetics, drugs, or foods
- Pregnant and lactating women
- People who had any cosmetic procedures before 4 weeks of the study
- Area of facial spot over 3 cm2
- Vegan
- People who took collagen supplements in the past 3 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: placebo group
subjects drank 50 ml every night for 14, 28 days
|
subjects drank 50 ml every night for 14, 28 days
|
Experimental: collagen drinks
subjects drank 50 ml every night for 14, 28 days
|
subjects drank 50 ml every night for 14, 28 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
skin moisture
Time Frame: subjects drank 50 ml every night for 28 days
|
using corneometer CM825 to examine skin moisture (The higher the value, the more water content, C.U., corneometer units )
|
subjects drank 50 ml every night for 28 days
|
skin elasticity
Time Frame: subjects drank 50 ml every night for 28 days
|
using cutometer dual MPA580 to examine skin elasticity (The closer the R2 value is to 1, the better the elasticity and no unit)
|
subjects drank 50 ml every night for 28 days
|
skin gloss
Time Frame: subjects drank 50 ml every night for 28 days
|
using probe system GL2000 & MPA10 to examine skin gloss (The higher the value, the higher the gloss, no unit)
|
subjects drank 50 ml every night for 28 days
|
skin spot
Time Frame: subjects drank 50 ml every night for 28 days
|
usig VISIA-CR to examine skin spot (The higher the value, the larger the pore area, mm2)
|
subjects drank 50 ml every night for 28 days
|
skin wrinkle
Time Frame: subjects drank 50 ml every night for 28 days
|
using VISIOSCAN-VC20 to examine skin wrinkle (The higher the value, the more wrinkles, surface evaluation of wrinkles, SEW)
|
subjects drank 50 ml every night for 28 days
|
skin roughness
Time Frame: subjects drank 50 ml every night for 28 days
|
using VISIOSCAN-VC98 to examine skin roughness (The higher the value, the higher the roughness, surface evaluation of roughness, SEr)
|
subjects drank 50 ml every night for 28 days
|
skin smoothness
Time Frame: subjects drank 50 ml every night for 28 days
|
using VISIOSCAN-VC98 to examine skin smoothness (The lower the value, the higher the smoothness, surface evaluation of smoothness, SEsm)
|
subjects drank 50 ml every night for 28 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chi Fu Chiang, Ph.D, Research & Design Center, TCI CO., Ltd
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2020
Primary Completion (Actual)
June 30, 2020
Study Completion (Actual)
August 31, 2020
Study Registration Dates
First Submitted
January 11, 2021
First Submitted That Met QC Criteria
January 12, 2021
First Posted (Actual)
January 14, 2021
Study Record Updates
Last Update Posted (Actual)
January 14, 2021
Last Update Submitted That Met QC Criteria
January 12, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EWISH-20190917-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Condition
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedPrecancerous/Nonmalignant ConditionUnited States
-
AI Labs Group S.LOsakidetza; Hospital Universitario Cruces; Servicio Vasco de Salud Osakidetza...RecruitingSkin Diseases | Skin ConditionSpain
-
TCI Co., Ltd.Recruiting
-
TCI Co., Ltd.Completed
-
TCI Co., Ltd.Active, not recruiting
-
TCI Co., Ltd.Completed
-
TCI Co., Ltd.Completed
Clinical Trials on placebo group
-
Pusan National University Yangsan HospitalCompletedDyspepsiaKorea, Republic of
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Active, not recruiting
-
University of Sao Paulo General HospitalCompletedSpinal Cord InjuriesBrazil
-
University of PernambucoUnknown
-
Karaman Training and Research HospitalRecruiting
-
Universidad Europea de MadridMinisterio de Economía y Competitividad, SpainCompleted
-
Universidad San SebastiánUnknownCervical Pain | Musculoskeletal ManipulationsChile
-
Pusan National University Yangsan HospitalCompletedSubjective Memory ImpairmentKorea, Republic of
-
RWTH Aachen UniversityTerminatedStroke | Upper Limb ParesisGermany
-
Université de SherbrookeAlzheimer's Association; Nestle Health ScienceRecruiting